Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Effimune logo — company profile

Effimune

Founded 2007 France France 1 employees

General Information

Company Name Effimune
Founded Year 2007
Location France France +1
Employees 1
Social

Get notified when Effimune moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Effimune

Effimune S.A.S. is a biotechnology company specializing in innovative drug candidates for transplantation and immune-mediated diseases. Founded in 2007 and headquartered in France, the company focuses on developing first-in-class biological drug candidates targeting the immune system's cells to restore the balance between effector and regulatory mechanisms. Effimune has three product candidates currently in development, with one in collaboration with Janssen Biotech. This partnership demonstrates the company's potential for growth and development in the biotechnology sector. With a strong focus on addressing critical medical needs, Effimune presents an intriguing opportunity for venture capitalists seeking to invest in cutting-edge solutions for transplantation and immune-mediated diseases.

No funding data available for Effimune yet.

Get notified when Effimune raises funding

Effimune Alternatives & Competitors

Effimune vs
Tolerx, Inc.
Tolerx, Inc. United States

Tolerx, Inc., a world leader in immunology, has a portfolio of innovative, first-in-class drug candi...

Series Unknown
9 employees
Biotechnology, Health Care
Effimune vs
Apollomics
Apollomics United States

We are a biopharmaceutical company committed to the discovery and development of mono- and combinati...

Post Ipo Equity
26 employees
Biotechnology, Health Care
Effimune vs
KSQ Therapeutics, Inc.
KSQ Therapeutics, Inc. United States

The company is deploying CRISPRomics for novel drug development across broad therapeutic areas and i...

Series C
60 employees
Biopharma, Biotechnology

FAQ About Effimune

Effimune S.A.S. is a biotechnology company conducting research and development of innovative drug candidates for transplantation and immune-mediated diseases. The company specializes in the development of first-in-class biological drug candidates targeting cells of the immune system to restore the...
Effimune was founded in 2007.
Effimune is headquartered in France.
Effimune has approximately 1 employees.
Top alternatives and competitors to Effimune include Tolerx, Inc., Apollomics, KSQ Therapeutics, Inc., Alligator Bioscience, Kangpu Biopharmaceuticals, Ltd.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Effimune and Tolerx, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Effimune and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy